UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013825
Receipt number R000016135
Scientific Title Expiratory randomized phase II trial for optimizing treatment dose and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer
Date of disclosure of the study information 2014/04/28
Last modified on 2022/03/16 13:24:16

No. Disposal Last modified on Item of update
1 Insert 2014/04/28 10:30:31
2 Update 2014/10/31 12:42:01 Primary outcomes
Key secondary outcomes
3 Update 2014/10/31 12:42:47 Name of person sending information
Name of person sending information
4 Update 2015/05/08 11:45:27 Recruitment status
5 Update 2015/10/13 18:28:28 Acronym
Acronym
6 Update 2015/10/13 18:55:35 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
Institutions
7 Update 2015/10/13 18:56:47 Recruitment status
8 Update 2015/10/14 16:31:03 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
9 Update 2018/05/01 09:16:58 Recruitment status
10 Update 2019/11/05 10:40:00 Number of participants that the trial has enrolled
11 Update 2019/11/05 10:42:20 Date of IRB
Last follow-up date
12 Update 2020/11/02 09:56:56 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Email

Last name of contact person

Last name of contact person
Zip code
Address
Email
Name of primary person or sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
13 Update 2021/11/02 09:32:06 Name of person sending information
Name of person sending information
Address
Address
TEL
14 Update 2022/03/16 13:24:16 Organization
Organization
Address
Address
TEL
Organization1
Address1
Tel1
Email1